Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong
Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong
About this item
Full title
Author / Creator
Publisher
Atlanta: U.S. National Center for Infectious Diseases
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: U.S. National Center for Infectious Diseases
Subjects
More information
Scope and Contents
Contents
In a cohort of persons living with HIV in Hong Kong, surrogate virus neutralization testing for COVID-19 yielded a median level of 89% after the third dose of an inactivated COVID-19 vaccine, compared with 37% after the second dose. These results support using a 3-dose primary series for enhanced immune protection.
Alternative Titles
Full title
Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0f07a24052fc4c6e92a05b84f45cdd6e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0f07a24052fc4c6e92a05b84f45cdd6e
Other Identifiers
ISSN
1080-6040
E-ISSN
1080-6059
DOI
10.3201/eid2810.220691
